Publication of NIBRT’s Annual Report 2023

DUBLIN, IRELAND, January 30 2024 – The National Institute for Bioprocessing Research and Training (NIBRT) today published its Annual Report for 2023 which highlights a 7% growth in revenue bringing research and training activity to the highest level in the Institute’s history. 

The success of the Irish biopharma industry is well documented, with biopharma firmly established as a key pillar of the Irish economy. There are 84,000 highly skilled people directly and indirectly employed in the sector and the expectation is that this will increase by up to 10,000 jobs over the next 5 years. 2023 saw continued strong performance of the sector with significant new developments including Astellas, Lilly, MSD, Novo Nordisk and others.  

NIBRT continued its strong support of the sector throughout 2023 with some of the key achievements in the year including: 

  • A 7% growth in overall revenue, bringing research and training activity to the highest level in the Institute’s history. 
  • 9% increase in training activity with client companies based in Ireland. 
  • 28% growth in research activity, underpinned by the joint appointment of new Principal Investigators in partnership with Irish and international universities.  
  • The signing of two new NIBRT global partnerships in the US. 
  • The opening of the Advanced Therapies building and the CONCEPT facilities. 

Simon Coveney TD, Minister for Enterprise, Trade & Employment commented “…the growth of the life sciences in Ireland has been a cornerstone of our economic success and we are proud of a thriving sector that brings high-quality jobs all around the country…in 2023 we also turned the page in terms of the types of medicines being developed in Ireland. Through IDA Ireland, the Government invested €20 million in the new Advanced Therapy expansion at the NIBRT. When the Taoiseach turned the sod at the site in 2022, we doubled down on our commitments to support innovative medical treatments and to help to train the next generation of researchers at the world leading NIBRT…” .  

Announcing the Annual Report NIBRT Chairperson, Julie O’Neill stated “I would like to congratulate all in the NIBRT team on another year of strong performance. NIBRT’s success continues to be built upon a spirit of partnership with stakeholders from across industry, academia and government. In particular, I would like to thank IDA Ireland and our colleagues in the IDA Life Sciences division for their continued support of the Institute. The NIBRT Board will continue to focus on the Institute’s central mission to help the growth and development of the biopharmaceutical manufacturing industry in Ireland.” 

NIBRT CEO, Darrin Morrissey, commented “NIBRT had a highly successful year in 2023 delivering our world-leading training and research services to clients nationally and internationally. I am delighted to report that 2023 saw the organisation achieving record levels of activity and out-performing 21 of the 22 targets set out in our 2019-2023 business plan. I would like to thank NIBRT’s Board and staff for their continued hard work, innovation and dedication to NIBRT’s training and research mission.” 

As the Institute looks forward to the opportunities ahead, NIBRT has identified a number of calls to action to continue to support the future growth of the sector in Ireland a continued focus on workforce development, building biopharma manufacturing research of scale alongside effective strategic planning and stakeholder coordination. 

The NIBRT 2023 Annual Report can be downloaded here:

Download

About NIBRT 

The National Institute for Bioprocessing Research and Training (NIBRT) is a global centre of excellence for training and research in biopharmaceutical manufacturing. NIBRT is located in a world class facility in Dublin, Ireland. This facility is purpose built to closely replicate a modern bioprocessing plant with state-of-the-art equipment and enables NIBRT to offer the highest quality training and research solutions. NIBRT’s mission is to support the growth and development of all aspects of the biopharmaceutical manufacturing industry. 

For more information go to www.nibrt.ie 
Emer Norton, NIBRT Marketing and Communications Manager, + 353 1 21500, emer.norton@nibrt.ie